Rudolf Valenta,Katarzyna Niespodziana,Johanna Edlmayr,Dieter Blaas,Verena Niederberger-Leppin,Nikos Papadopoulos,Theresia Popow-Kraupp
申请号：
US13504766
公开号：
US20120213820A1
申请日:
2010.11.02
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising at least one peptide consisting of a minimum of 8 and a maximum of 50 amino acid residues comprising amino acid residues 1 to 8 of a rhinovirus capsid protein selected from the group consisting of VP1, VP2, VP3 and VP4.
